Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted.

Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse ...

Researchers looked at health information for over 300 patients. Forshee suggested a similar change for Pfizer’s Comirnaty vaccine, which was approved in August 2021.

Starboard Value is knocking on Pfizer’sPFE-2.92%decrease; red down pointing triangle door, demanding the drugmaker make changes to improve performance. The problem for the company and its new ...

Health. Pharma; Pfizer Has a New Playbook for Reviving Sales—and It’s Starting to Pay Off. ... Pfizer now credits that and other changes for a 31% increase in Nurtec’s U.S. sales last year.

Pfizer on Tuesday said it does not expect the Trump administration to make major changes to vaccine policy next year even as the president-elect has put forward vaccine skeptic Robert F. Kennedy ...

Pfizer declared that the platform is needed as consumers battle a confusing healthcare system. PfizerForAll will support patients with conditions like migraines, Covid-19 or the flu.

The Federal government's long-term budget challenges could mean dramatic changes for hospitals and health systems nationwide, derailing the post-COVID credit recovery that helped turn the ...

Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.